Patient recruitment is a major barrier in clinical trials. This involves the identification of patients, screening them for inclusion/exclusion criteria of a given clinical trial,
Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for understanding the disease’s natural history, palliative treatments that focus primarily on
Wed, October 26, 2022 at 5:35 PM-6 min read Clinical trials rely on volunteer populations that can be challenging to access and monitor. Inadequate diversity
JoTo PR Disruptors’ signs Jeeva Trials, a human-centric Software as a Service (SaaS) company that is working to revolutionize the clinical trials space at scale.
Clinical trials are expensive, take significant time, and can run into any number of challenges and delays. The average drug study will see a 30%
Source: PubsOnline Over the past two years, the testing of new medical devices, drugs and vaccines has increasingly been performed outside large medical centers. Faster
Source: ACRP There’s more to the quest of fostering diversity, equity, and inclusion in the delivery of clinical research opportunities than just reaching race/ethnicity-, gender-,
Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development February 22, 2022 February is Rare Disease Month—an important time when
Source: Insightcare By Harsha Rajasimha, PhD, Founder and CEO, Jeeva Clinical Trials Inc. www.jeevatrials.com To say that COVID-19 has been a challenge to healthcare systems
The COVID-19 pandemic brought a new sense of appreciation for clinical trials as masses watched clinical trials closely while pharmaceutical companies raced against the clock
Jeeva Clinical Trials Inc.
